The genetic study by scientists investigating acute myeloid leukaemia could lead to potentially life-saving personalised treatments.Read the full story ›
"It was an unbelievable moment to finally meet Sue in person and give her a big hug - she's my hero."Read the full story ›
Felix Brown has been hailed a "star" and an "inspiration" as he charts his treatment on Facebook after being diagnosed six weeks ago.Read the full story ›
Four-year-old Tommy Simpson was diagnosed with leukaemia last month and has been in hospital since Christmas.Read the full story ›
One little girl's amazing response to an experimental leukaemia treatment could change the face of the fight against the disease.Read the full story ›
A charity has said family doctors need to be able to spot more cases of blood cancer at an earlier stage.
Leukaemia Care said GPs need better knowledge of blood cancers such as leukaemia so they can help diagnose patients when their cancer is at an earlier stage.
More than half of patients with the condition are only diagnosed after they have gone to hospital as an emergency case, the charity said.
This often means that their cancer is at a more advanced stage and can be harder to treat.
Thousands of Christmas carollers gathered to sing outside the home of a terminally ill Pennsylvania girl this weekend.Read the full story ›
Former US President George Bush Sr has shaved his head in a show of support for a 2-year-old boy who is battling leukaemiaRead the full story ›
The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
The brighter outlook for young leukaemia sufferers is because they tend to have types of the disease which are easier to treat with chemotherapy.
Younger people can also generally be given more intense treatment, and the short-term side effects can now be managed effectively.
Around 2,500 people are diagnosed with acute myeloid leukaemia (AML) in the UK each year.
The risk of developing it increases with age and it is most common in people over 65 years old.